MYCBD is a simple, unique genetic test. With just a cheek swab, we give a patient and their doctor critically important clinical information. We objectively determine if a patient is a strong candidate for Medical Cannabis use. We all know our Nation is in the throes of a Narcotic and Prescription Drug Epidemic. With 50 million americans taking pain pills daily, and another 20 million using sleeping pills and anxiolytics, we have become a country addicted to prescription drugs. While CBD has become incredibly popular over the past two years, no one can objectively determine if CBD is right for them - until now. The MYCBD genetic test scientifically determines a patient’s individual CBD receptor profile.

Unlocking a patient’s CBD Genetics is the key to elevating their personal experience with CBD and reducing their reliance on prescription drugs. Our simple cheek swab breaks down a patient’s CBD receptor activity in a simple to read chart. Our test is two-fold. First, the test will quantify and categorize your unique CBD and THC receptor profile. A patient’s unique receptor profile objectively determines the likelihood they will perform well on Medical Cannabis. Second, the MYCBD genetic test specifically determines a patient’s genetic variance and mutations at the CNR1 and CNR2 receptors. By studying the benefits of CBD and THC on hundreds of patients, and cross referencing Cannabinoid Receptor genetic variance and mutations, we will be able to not just recommend CBD or THC for varied disease processes. We feel we will be able to match a patient's disease process to a specific strain, concentration and dose of CBD or THC to optimize their therapeutic benefits. The MYCBD cheek swab may just be the solution our medical community needs to end the Narcotic Epidemic.